The Valley Desk

NCT02848326 · Interventional trial

Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention

Overall registry status Completed

Phase 2 · Phase 3

Conditions Migraine, With or Without Aura

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov